Company Overview and News

Melbana Energy eyes world-class oil exploration block in Cuba

Melbana Energy (ASX:MAY) has recently updated the exploration potential of its onshore Block 9 in Cuba to 12.5 billion barrels of oil-in-place with prospective resources of 637 million barrels of oil.
Upvote Downvote

TAG Oil Reports Q2 2017 Results and Updates Recent Activities

2016-11-15 prnewswire
VANCOUVER, Nov. 14, 2016 /PRNewswire/ - Oil and gas exploration and production company, TAG Oil Ltd. (TSX: TAO and OTCQX: TAOIF, "TAG") is pleased to report second quarter results for the fiscal year ending March 31, 2017, in which oil and gas production increased and continues to be steady and is above guidance with a current net daily average rate of 1,227 BOE/d (83% Oil) over the month of November to date.
Upvote Downvote

Notice of AGM

2016-10-21 londonstockexchange
Range advises of its Notice of Annual General Meeting ("Notice"). The meeting will be held on Friday, 25 November 2016 at 10.00 am (GMT) at 9 Adam Street, London, WC2N 6AA, United Kingdom. Instructions on voting are included in the Notice of Meeting.
Upvote Downvote

Annual Report 2016

2016-10-03 londonstockexchange
Range today releases the financial report for the year ending 30 June 2016.  A copy of the full Annual Financial Report is available on the Company's website and also the Australian Securities Exchange website (ASX code: RRS).
Upvote Downvote

MEO Australia Seeks Shareholder Approval to Rename Firm as Melbana Energy

2016-09-28 rigzone
Melbourne-based oil and gas firm MEO Australia Ltd. reported Wedensday that it planned to relaunch the company as Melbana Energy Ltd., with the name change subject to shareholder approval.
Upvote Downvote

MEO still seeking partner for Beehive Prospect in WA-488-P

2016-09-12 energyglobal
MEO Australia Limited has provided the following update for the farmout process for WA-488-P (MEO 100%) containing the giant Beehive prospect.
Upvote Downvote

MEO Australia: 4 Companies Interested in Beehive Farm-Out Deal

2016-09-12 rigzone
MEO Australia Limited revealed Monday that four substantial companies have engaged in a farmout process for the Beehive prospect and are actively reviewing the technical data for WA-488-P.
Upvote Downvote

MEO Australia Ltd to raise $1.69M for Cuban oil exploration

MEO Australia Ltd (ASX:MEO) has accepted commitments to raise about $1.69 million via the placement of shares at $0.036 each, to progress its oil exploration activities in northern Cuba. A number of existing shareholders showed support for the placement and the company has welcomed a number of new investors to its share register. The proceeds from the placement will be used to accelerate MEO’s onshore exploration activities on Block 9 in Cuba, including the preparation of a drilling program for up to two wells in Block 9.
Upvote Downvote

MEO Australia raises US$1.69 million for Cuba exploration

2016-08-18 energyglobal
MEO Australia Ltd has announced that it has accepted commitments to raise approximately US$1.69 million through a placement of approximately 46.9 million shares at US$0.036 per share to qualified institutional and sophisticated investors. A number of existing shareholders showed strong support for the Placement and the Company has welcomed a number of high quality new investors to its share register.
Upvote Downvote

MEO Australia Ltd heads to market

MEO Australia Ltd (ASX:MEO) is an ASX listed, independent oil and gas company focused on building a substantial Australian and international E&P business servicing the rapidly growing Asian energy markets.
Upvote Downvote

TAG Oil announces quarterly results

2016-08-15 oilvoice
Oil and gas exploration and production company, TAG Oil Ltd. (TSX: TAO and OTCQX: TAOIF) is pleased to report first quarter results for the fiscal year ending March 31, 2017, in which the Company has continued with its strategy to preserve capital by continuing to reduce its capital expenditures and focus on field optimization opportunities, prospect generation and capitalize on distressed asset acquisitions.
Upvote Downvote

MEO Australia Provides Update on Projects in Australia, NZ & Cuba

2016-08-15 rigzone
MEO Australia Ltd. provided an update Monday on the progress and near term plans of the company’s key projects in Australia, New Zealand and Cuba.
Upvote Downvote

MEO Australia Gets Updated Environmental Consents for Tassie Shoal Projects

2016-08-04 rigzone
MEO Australia Ltd. reported Thursday that the firm has received updated environmental approvals extending the approvals period for the liquefied natural gas (LNG) development of the Tassie Shoal Projects offshore Northern Australia, enhancing the flexibility to process gas of varying qualities into LNG.
Upvote Downvote

Investee Company Update: MEO Block 9 Oil Resource

2016-07-07 londonstockexchange
London, Havana: 7 July 2016:  London listed Cuban specialist investment company, Leni Gas Cuba Limited is pleased to announce that it's 15.8% owned Australian and Cuban oil and gas explorer, MEO Australia Limited ("MEO"), has today provided a significant update in relation to its 2,380 km2 onshore Block 9 Production Sharing Contract ("Block 9 PSC"), located on the north coast of Cuba, 140 km east of Havana and along trend with the multi-billion barrel Varadero oil field.
Upvote Downvote

MEO Australia Ltd is Thursday's ASX Most Traded with 82 million

MEO Australia Ltd (ASX:MEO) is an ASX listed, independent oil and gas company focused on building a substantial Australian and international E&P business servicing the rapidly growing Asian energy markets.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...